Growth Metrics

Mannkind (MNKD) Receivables - Other (2010 - 2023)

Mannkind (MNKD) reported Receivables - Other of $400000.0 for Q3 2023, down 33.33% year-over-year from $600000.0 in Q3 2022, and up 100.0% on a QoQ basis from $200000.0 in Q2 2023.

Mannkind (MNKD) has 9 years of Receivables - Other data on file, last reported at $400000.0 in Q3 2023.

  • Quarterly Receivables - Other fell 33.33% year-over-year to $400000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $400000.0 (down 33.33% YoY) and the FY2021 annual result came in at $255000.0, changed N/A from the prior year.
  • Receivables - Other grew to $400000.0 in Q3 2023 per MNKD's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $5.0 million in Q2 2019 and bottomed at $200000.0 in Q2 2023.
  • The 4-year median for Receivables - Other is $450000.0 (2022), against an average of $1.0 million.
  • Peak annual rise in Receivables - Other reached 40.0% in 2023, while the deepest fall reached 50.0% in 2023.
  • Tracing MNKD's Receivables - Other over 4 years: stood at $5.0 million in 2019, then sank by 94.0% to $300000.0 in 2021, then surged by 100.0% to $600000.0 in 2022, then sank by 33.33% to $400000.0 in 2023.
  • Per Business Quant, the three latest MNKD Receivables - Other figures stand at $400000.0 (Q3 2023), $200000.0 (Q2 2023), and $700000.0 (Q1 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Sep 30, 2022 600,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Jun 30, 2019 5.00 Mn
Jun 30, 2019 5.00 Mn
Sep 30, 2014 803,000.00
Sep 30, 2014 803,000.00
Sep 30, 2013 298,000.00
Sep 30, 2013 298,000.00
Jun 30, 2013 450,000.00
Jun 30, 2013 450,000.00
Mar 31, 2013 450,000.00
Mar 31, 2013 450,000.00
Dec 31, 2012 450,000.00
Dec 31, 2012 450,000.00
Sep 30, 2011 765,000.00
Sep 30, 2011 765,000.00
Dec 31, 2010 674,000.00
Dec 31, 2010 674,000.00